 |
|
“IN TIMES OF CHANGE, LEARNERS INHERIT THE EARTH WHILE THE LEARNED FIND THEMSELVES BEAUTIFULLY EQUIPPED TO DEAL WITH A WORLD THAT NO LONGER EXISTS.”
— ERIC HOFFER
|
|
 American health care continues to spiral toward a crisis of unaffordability and inequity at a time when the health needs of our nation and the world are critically acute. Current methods are not serving us well.
With change crucial, learning becomes the key. I am convinced my colleagues in the Institute and Park Nicollet Health Services not only value learning as a way to manage change, but are collectively positioned to create change to address health problems.
We have already fostered breakthrough innovations in medical research, studies that inform national health policy and health education programs that demonstrate effectiveness in preventing and reducing suffering throughout the world.
And, we continue to look ahead. In the context of this health care crisis, Park Nicollet Institute’s long-term goals targeting innovation in chronic illness and reductions in health disparities never have been more relevant.
My predecessor, A. Stuart Hanson, MD, often said, “When you’re through changing, you’re through.” It’s a bit of eastern philosophy that relates to the Institute’s consistent growth throughout Stu’s tenure as our leader. Our staff has grown together as scholars and leaders, we’ve grown in our commitment to understanding our customers and meeting community needs and, not surprisingly, given our dedication to innovation, we’ve grown in size and revenue.
In 2002, Stu embarked on his latest change and it’s not looking at all like semi-retirement. He’s introducing new clinical services in pulmonary medicine, sponsoring a conference on workplace abuse prevention and still serving the community on numerous boards and panels.
It’s also been an impressive year of growth for the Institute. Take a look at the statistics and accomplishments noted throughout this report. Individually, they are impressive. Collectively, they represent a tremendous connection to learning and change.
It has been said that as an elder, Pablo Picasso was monitored when he walked through art galleries because he had been caught trying to improve his masterpieces. Picasso said, “I am always doing that which I cannot do, in order that I may learn how to do it.” Like Picasso’s friends, I’m keeping an eye on Stu as our new leadership team builds on his legacy. And like Stu, the Institute staff is far from through making changes. Stu, our customers and the world can depend on that.
Paul E. Terry, PhD
President and Chief Executive Officer
Park Nicollet Institute
|
|
| PARK NICOLLET INSTITUTE ENGAGES IN RESEARCH, EDUCATION AND INNOVATION TO IMPROVE QUALITY AND PUBLIC AND PRIVATE DECISION-MAKING IN HEALTH AND HEALTH CARE. |
|
This active and ambitious mission requires that Institute strategies continue to evolve and develop. Our specific goals surrounding customer needs, chronic disease, health disparities and staff excellence are supported by purposeful growth. The highlights on these pages and throughout this report show initiatives to grow programs, market share and revenue — all in the spirit of our mission.
|
|
|
TEACHING MORE PEOPLE
 HealthSource added fitness center management contracts with Walser Automotive Group and United Defense, bringing their total to 10 centers at seven different Twin Cities corporations. They also provided substantial new worksite health promotion initiatives at numerous companies. Almost 4,000 people enrolled in 300-plus health education classes, services and forums. More than 8,000 health professionals attended our continuing medical education programs.
REARCHING MORE MARKETS
With worldwide demand for our diabetes books and patient materials high, International Diabetes Center’s publications team surpassed the $1 million mark in gross revenue. HealthSource sold more than 378,000 of its pyramid products. The publishing and product development teams of these two groups have now merged to more effectively bring Park Nicollet expertise to organizations nationwide.
Next page: Helping more patients, asking more questions.
|
ASKING MORE QUESTIONS
The Institute coordinated more than 170 active research studies in 2002. In addition, the Metro-Minnesota Community Clinical Oncology Program (CCOP) enrolled nearly 900 new participants into cancer prevention and control, treatment and pharmaceutical-sponsored studies.
|
HELPING MORE PATIENTS
International Diabetes Center opened the Annual Checkup and Assessment Service to provide people with diabetes a comprehensive evaluation, complete with testing and review of all standards of care needed to detect and prevent diabetes complications — all in one visit. Assessment Service and diabetes education patient visits and revenue are on the rise and positioned for growth.
Back
|
|
| |
|
|
ACCOMPLISHMENTS IN EDUCATION, RESEARCH AND INNOVATION.
|
OUR WORK
 |
International Diabetes Center and Park Nicollet’s Supporting Best Care team collaborated to implement our diabetes education and care solutions throughout Park Nicollet. The results were recognized by The National Committee for Quality Assurance/American Diabetes Association, HealthPartners, HealthFront and Park Nicollet Health Services. |
|
Health Research Center received funding from Agency for Healthcare Research and Quality to evaluate
a report card produced by
HealthCare 21. The findings from this comparative report of hospital performance in Tennessee will address policy questions about the impact and utility of public disclosure of hospital patient safety measures. |
|
Park Nicollet HealthSource hosted the first Midwest Worksite Health Promotion Conference for more than 200 human resources, occupational health and worksite health promotion professionals. |
|
Institute President Paul Terry traveled to Zimbabwe to work with SHAPE Zimbabwe, a nongovernmental organization dedicated to improving health, preventing HIV and reducing the suffering of those living with AIDS. Funded by The Pfizer Foundation, this project aims to improve health literacy related to HIV prevention in Africa. |
|
Health Education Center revised Park Nicollet’s “Preparing for Childbirth” curriculum based on phone surveys and feedback from past participants, instructors and our obstetrics department. They also developed an education initiative to improve the childbirth experiences of Somali mothers. |
|
Through a grant from the Centers for Disease Control and Prevention to the Minneapolis Medical Research Foundation, Park Nicollet will participate in a five-year study of the unnatural history of AIDS with funding possibly reaching more than $750,000 for the enrollment of up to 60 patients. |
|
International Diabetes Center joined American Association of Diabetes Educators and Taking Control of Your Diabetes to lead “Aim. Believe. Achieve.” — a national education initiative to help patients and providers understand the importance of achieving an A1c level below 7 percent. |
|
|
Park Nicollet Institute earned Charity Navigator's four-star rating, its highest. This charity watchdog service evaluates the financial health of more than 1,700 American charities by providing ratings on short-term spending, long-term sustainability and peer analysis. |
|
To address childhood obesity and the related risk of diabetes, International Diabetes Center developed "Being Healthy Rocks," a unique publication targeted at young people that demonstrates fun approaches to healthy eating and increased activity. The new "Staged Diabetes Management QuickGuide to Detection and Treatment of Metabolic Syndrome and Type 2 Diabetes in Children and Adolescents" also addresses this emerging crisis. |
|
Metro-MN CCOP partnered with cancer researchers, payers and providers to help Minnesotans gain easier access to clinical trials. They presented a recommendation, "Voluntary Program to Clarify Health Plan Reimbursement of the Costs of Routine Care Provided in Cancer Clinical Trials," to the Minnesota Legislature. |
|
Through "Partners in Advancing Care and Education Solutions," supported by an $800,000 Novartis Pharmaceuticals grant, International Diabetes Center will bring its education and care solutions to 12 sites nationwide. |
|
OUR PEOPLE
|
Jinnet B. Fowles, PhD, Health Research Center, joined AcademyHealth’s membership committee and the national advisory panel on quality indicators of the American Nurses Association.
|
|
A. Stuart Hanson, MD, Institute board member and former president, received the Recognition of Excellence Award from the Academic Health Center at the University of Minnesota for his outstanding contributions and achievements in teaching, research and science. |
|
David Knutson, Health Research Center, was appointed to the National Advisory Panel on Medicare Education. |
|
Oncology Research Program’s Alice Shapiro, PhD, was appointed by former Governor Jesse Ventura to the office of Licensed Nutritionist with the Board of Dietetics and Nutrition Practice. |
|
|
|
|
IN 1989, THE INSTITUTE ESTABLISHED AWARDS TO RECOGNIZE OUTSTANDING CONTRIBUTIONS TO RESEARCH AND EDUCATION. THE AWARDS REFLECT THE TRADITIONS ESTABLISHED BY OUR FOUNDERS TO DEVOTE TIME TO RESEARCH, ADVANCE PATIENT CARE AND SUPPORT ONGOING PROFESSIONAL EDUCATION.
2002  RESEARCHER OF THE YEAR
DAVID M. KENDALL, MD
Dr. Kendall, pictured with fellow researcher Mary Johnson, is the Institute’s vice president for education, chief of clinical services and medical director for International Diabetes Center. He also is a clinical consultant in endocrinology at Park Nicollet Clinic.
2002 EDUCATOR OF THE YEAR
DEBORAH THORP, MD
Dr. Thorp, pictured with health educator Laura Olevitch, is a physician in Park Nicollet’s obstetrics and gynecology department. She also is an associate clinical professor for obstetrics and gynecology and assistant professor for family practice at the University of Minnesota.
RESEARCHERS OF THE YEAR 1989-2001
2001 Martin Lee, MD
2000 Todd Tuttle, MD
1999 Roger Mazze, PhD
1998 John Schousboe, MD
1997 Richard Bergenstal, MD
1996 David Graft, MD
1995 George Cembrowski, MD, PhD
1994 Donald Pine, MD
1993 Mark Haugland, MD
1992 Jinnet Fowles, PhD
1991 Renner Anderson, MD
1990 Donnell Etzwiler, MD
1989 William Schoenwetter, MD
EDUCATORS OF THE YEAR 1989-2001
2001 A. Stuart Hanson, MD
2000 David Kendall, MD
1999 Allan Kind, MD
1998 Michael Dukinfield, MD
Joseph Nelson, MA, LP
1997 Frederick Taylor, MD
1996 George Strauss, MD
1995 Richard Woellner, MD
1994 Renner Johnston, MD
1993 Marion Franz, RD, MS
1992 Donnell Etzwiler, MD
1991 David Williams, MD
1990 Scott Strickland, MD
1989 H. Spencer Holmes, MD
|
|
RESEARCHERS FROM THE ENTIRE PARK NICOLLET SYSTEM PARTICPATED IN A WIDE RANGE OF STUDIES IN 2002.
|
|
Administration
Quality Improvement and Clinical Systems
Principal Investigator: Lawrence An, MD, University of Minnesota
Sponsor: Minnesota Medical Foundation
Project QUEST: Organizational Factors and Quality of Chronic Disease Care
Principal Investigator: Patrick O'Connor, MD, MPH, HealthPartners Research Foundation
Sponsor: Agency for Healthcare Research and Quality
Lyme025-A Cohort Study-Safety Reporting on Participants Receiving Lyme Vaccine (Post Marketing Surveillance)
Principal Investigator: Peter Harper, MD, HealthPartners Research Foundation
Sponsor: GlaxoSmithKline
Anticoagulation Clinic
A Double-Blind Efficacy and Safety Study of a New Oral Direct Thrombin Inhibitor Versus Standard Therapy Enoxaparin and Warfarin (Coumadin) in Patients with Acute, Symptomatic Deep Venous Thrombosis with or without Pulmonary Embolism
(Thrive 5)
Principal Investigator: Bruce Burnett, MD
Sponsor: AstraZeneca LP
Asthma and Allergy
A 12-Week, Randomized, Double-Blind, Double-Dummy, Active-Controlled Study of an Inhaled Corticosteroid pMDI Administered Once Daily in Children and Adolescents 6 to 15 Years of Age with Asthma (SPROUT)
Principal Investigator: Richard Wyatt, MD
Sponsor: AstraZeneca LP
A Multicenter, Double-Blind, Randomized, Parallel Study Comparing the Efficacy and Safety of an Antihistamine 120 mg. BID, 240 mg. QD, and Placebo in Subjects with Perennial Allergic Rhinitis
Principal Investigator: Richard Sveum, MD
Sponsor: Aventis Pharmaceuticals
A Phase IIIA, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study on the Efficacy and Safety of an Antihistamine 100 mg. Once Daily in Chronic Idiopathic Urticaria
Principal Investigator: Richard Wyatt, MD
Sponsor: Aventis Pharmaceuticals
A 12-Week, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Trial of an Inhaled Corticosteroid/ Long-Acting Bronchodilator Combination (80/4.5 mcg.) versus its Mono-Products (an Inhaled Corticosteroid and a Long-Acting Bronchodilator) in Children (6 years of age and older) and Adults with Asthma
Principal Investigator: Pamela Harris, MD
Sponsor: AstraZeneca LP
Back
A Phase II, Randomized, Blinded, Placebo-Controlled, Multiple-Dose, Dose-Finding Study to Evaluate the Safety and Clinical Activity of an Anti-CD23 Monoclonal Antibody in Patients with Ragweed-Induced Seasonal Allergic Rhinitis
Principal Investigator: William Schoenwetter, MD
Sponsor: IDEC Pharmaceuticals Corporation
A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy and Safety of an Antihistamine 120 mg. BID in Subjects with Mild to Moderate Persistent Asthma
Principal Investigator: Richard Sveum, MD
Sponsor: Aventis Pharmaceuticals
A Multicenter, Open-Label, Randomized, Parallel-Group Study to Assess the Long Term Safety Performance of an Antihistamine Compared to an Oral Leukotriene Antagonist in Subjects with Asthma
Principal Investigator: William Schoenwetter, MD
Sponsor: Aventis Pharmaceuticals
A Randomized, Double-Blind, Multicenter Study to Evaluate the Effect of an Oral Leukotriene Antagonist versus an Inhaled Corticosteroid in Patients with Mild Persistent Asthma
Principal Investigator: Pamela Harris, MD
Sponsor: Merck & Co. Inc.
A Multicenter, Randomized, Controlled, Open-Label Study to Evaluate the Safety of a Monoclonal Antibody in Moderate to Severe, Persistent Asthma Subjects Already Treated with Other Therapies (ALTO)
Principal Investigator: David Graft, MD
Sponsor: Genentech Inc.
Placebo-Controlled Efficacy and Safety Study of a Once-Daily PM and BID Regimens of an Inhaled Corticosteroid Administered via Dry Powder Inhaler in Subjects with Asthma Who were Previously Maintained on Inhaled Corticosteroids
Principal Investigator: Richard Sveum, MD
Sponsor: Schering Corporation
A Phase III, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled Study of a New Inhaled Corticosteroid 800 µ/Day and 1600 µ/Day Administered Twice Daily for 16 Weeks to Determine Effectiveness to Reduce Oral Corticosteroid (OCS) Use in Oral Corticosteroid-Dependent Patients with Severe Persistent Asthma
Principal Investigator: Richard Wyatt, MD
Sponsor: Aventis Pharmaceuticals
An Open-Label Extension Study of a New Monoclonal Antibody in Moderate to Severe, Persistent Asthma Subjects Who Completed the ALTO Study
Principal Investigator: David Graft, MD
Sponsor: Genentech Inc.
A Stratified, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Trial Evaluating the Safety and Efficacy of an Inhaled Corticosteroid/Long-Acting Bronchodilator Combination Product Given by DISKUS Inhaler 100/50µ Once-Daily vs. an Inhaled Corticosteroid Given by DISKUS Inhaler 100µ Once-Daily and Placebo in Symptomatic Pediatric Subjects (4-11 years) with Asthma
Principal Investigator: Richard Wyatt, MD
Sponsor: GlaxoSmithKline
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Trial Evaluating the Efficacy and Safety of Two Different Doses of an Inhaled Corticosteroid/Long-Acting Bronchodilator Product Given by DISKUS Inhaler Once or Twice Daily vs. an Inhaled Corticosteroid Given by DISKUS Once-Daily Versus Placebo in Symptomatic Adolescent and Adult Subjects with Asthma that is Not Controlled on Short-Acting Beta2 Agonists Alone
Principal Investigator: Pamela Harris, MD
Sponsor: GlaxoSmithKline
A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group, 16-Week Comparison of Asthma Control in Adolescents and Adults receiving either an Inhaled Corticosteroid/Long-Acting Bronchodilator Combination Product Given by DISKUS 100/50µ BID, a Long-Acting Bronchodilator Given by DISKUS 100µ BID, a Long-Acting Bronchodilator Given by DISKUS 50µ BID, or an Oral Leukotriene Antagonist QD
Principal Investigator: William Schoenwetter, MD
Sponsor: GlaxoSmithKline
A Multicenter, Randomized, Placebo-Controlled, Parallel-Group Study Investigating the Clinical Effects of an Oral Leukotriene Antagonist in Patients with Perennial Allergic Rhinitis
Principal Investigator: Richard Sveum, MD
Sponsor: Merck & Co. Inc.
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, 12-Week Study of Two Different Doses of an Inhaled Corticosteroid Delivered via CFC MDI and a Valved Holding Chamber with Facemask in Subjects with Asthma Aged 24 Months to 47 Months
Principal Investigator: Richard Wyatt, MD
Sponsor: GlaxoSmithKline
A Randomized, Multicenter, Placebo-Controlled, Parallel-Controlled, Parallel-Group Study of Four Months Duration Per Patient to Evaluate the Safety and Efficacy of Treatment with 24µG BID and 12µG BID of a Long-Acting Bronchodilator, Double-Blind, and 12µG BID with Additional On-Demand Doses of the Long-Acting Bronchodilator, Open-Label, in Adolescent and Adult Patients with Persistent Stable Asthma
Principal Investigator: David Graft, MD
Sponsor: Novartis Pharmaceuticals
Back
Cardiology
Efficacy and Safety of a New Oral Direct Thrombin Inhibitor Compared with Dose Adjusted Warfarin (Coumadin) in the Prevention of Stroke and Systemic Embolic Events in Patients with Atrial Fibrillation (SPORTIF V)
Principal Investigator: J. Mark Haugland, MD
Sponsor: AstraZeneca LP
Pravastatin or Atorvastatin Evaluation and Infectious Therapy (PROVE IT)
Principal Investigator: Gary Cramer, MD
Sponsor: Bristol-Myers Squibb Company
Pain Free Rx II (Does PacINg Fast VT ReducE Shock Rx?)
Principal Investigator: Wayne Adkisson, MD
Sponsor: Medtronic Inc.
Primary Angioplasty with Tirofiban in a Community Hospital (PATCH) Methodist Hospital Study of Major Adverse Events (MACE) in Tirofiban-Assisted Primary Angioplasty for Acute Myocardial Infarction
Principal Investigator: Jackson Thatcher, MD
Sponsor: Merck & Co. Inc.
Monitoring the Troponin Complex, Brain Natiuretic Peptide, and C-Reactive Protein in Patients with Congestive Heart Failure: Longitudinal Follow-up and Relationship to Length of Stay
Principal Investigator: John Thomas Suh, MD
Sponsor: Park Nicollet Institute
Cardiothoracic Surgery
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug-Device Combination in the Treatment of Coronary Vein Grafts in Patients Undergoing Coronary Artery Bypass Graft Procedures
Principal Investigator: Ted Spooner, MD
Sponsor: Corgentech
Center for Senior Health Services
Take Control: A Group-Based, Self-Management Program for Women with Urinary Incontinence
Principal Investigator: Jean Wyman, PhD, RN, University of Minnesota
Sponsor: Association of Rehabilitation Nurses
Eating Disorders Institute
The Effect of an Oral Contraceptive on Bone Mineral Density in Pediatric Subjects with Anorexia Nervosa: A Double-Blind, Placebo-Controlled Study
Principal Investigator: Scott Crow, MD
Sponsor: Ortho-McNeil Pharmaceutical Inc.
Assessing the Management of Eating Disorders in Family Practice
Principal Investigator: Jillian Croll, MS, RD, MPH
Sponsors: Park Nicollet Institute; Park Nicollet Foundation
Eating Disorders Stage of Change: Reliability and Validity of a New Measure
Principal Investigator: Diann Ackard, PhD, LP
Sponsor: Park Nicollet Institute
Back
Emergency Center
Public Access Defibrillation Trial: Early Access to Defibrillation for Victims of Out of Hospital Cardiac Arrest (OOH-CA)
Principal Investigator: Brian Mahoney, MD, Hennepin County Medical Center
Sponsors: National Heart, Lung, and Blood Institute; Survivalink; Agilent Technologies; Medtronic Inc.; Guidant Foundation; American Heart Association
Family Practice
Evaluation of Tobacco Cessation Services in Primary Care Practice
Principal Investigator: Don Pine, MD
Sponsor: American Academy of Family Practice
Gastroenterology
A Randomized, Open-Label, Multicenter, Phase III Study Evaluating the Efficacy and Safety of a New Medication in Combination with Ribavirin Given for 24 Weeks Versus 48 Weeks Versus No Treatment in Patients with Chronic Hepatitis C and Persistently Normal ALT Levels
Principal Investigator: Ann Kools, MD
Sponsor: Hoffman-LaRoche Inc.
ERCP Outcome Study (ERCOST)
Principal Investigator: Martin Freeman, MD, Hennepin County Medical Center
Sponsor: Minneapolis Medical Research Foundation
Health Information Management
Minnesota Heart Survey
Principal Investigator: Catherine Borbas, PhD, MPH, Healthcare Education and Research Foundation
Sponsor: National Heart, Lung, and Blood Institute
Atherosclerosis Risk in Communities (ARIC) Study
Principal Investigator: Aaron Folsom, MD, University of Minnesota
Sponsor: National Heart, Lung, and Blood Institute
Community Surveillance of Congestive Heart Failure
Principal Investigator: Eyal Sharer, MD, PhD, University of Minnesota
National Heart, Lung, and Blood Institute
Health Research Center
Colon Cancer Survivors: Medication and Risk of Recurrence
Principal Investigator: Sharon Rolnick, PhD, HealthPartners Research Foundation
Sponsor: National Cancer Institute
Cancer Surveillance in HMO Administrative Data
Principal Investigator: Feifei Wei, PhD, HealthPartners Research Foundation
Sponsor: National Cancer Institute
Women’s Perception of Cardiovascular Disease Risk
Principal Investigator: David Homans, MD
Sponsor: Park Nicollet Institute
Smoking Related Attitudes and Practices of Physicians and Nurses
Principal Investigator: Barbara Braun, PhD
Sponsor: Minnesota Partnership for Action Against Tobacco
Purchaser/Provider Evaluation: Hospital Quality Data, TN
Principal Investigator: Barbara Braun, PhD
Sponsor: Agency for Healthcare Research and Quality
Consumer Response to Clinic-Level Comparative Reports
Principal Investigator: Jinnet Fowles, PhD
Sponsor: Agency for Healthcare Research and Quality
Tobacco Cessation at Park Nicollet Health Services: Preliminary Assessment of the Clinical Environment
Principal Investigator: Barbara Braun, PhD
Sponsor: Park Nicollet Institute
Which Patients Want to Examine Their Medical Record?
Principal Investigator: Jinnet Fowles, PhD
Sponsor: Tonkawa Inc.
Employee Evaluation of a Defined Contribution Project: Post Enrollment Survey
Principal Investigator: Jinnet Fowles, PhD
Sponsor: Humana Inc.
Park Nicollet HealthSource
Healthy Young Workers Project: A Demonstration Project to Implement and Evaluate Promising Policy Change Initiatives with 18-24 Year-Olds
Principal Investigator: Ted Wegleitner
Sponsor: Minnesota Partnership for Action Against Tobacco
Infectious Disease
A Phase III, Open-Label, Randomized, Active-Controlled Study Assessing the Efficacy and Safety of a New HIV-1 Fusion Inhibitor in Combination with an Optimized Background Regimen, Versus Optimized Background Regimen Alone, in Patients with Prior Experience and/or Prior Documented Resistance to Each of the Three Classes of Approved Antiretrovirals (Nucleoside Reverse Transcriptase, Non-Nucleoside Reverse Transcriptase and Protease Inhibitors)
Principal Investigator: Harold Martin, MD
Sponsors: Hoffman-La Roche Inc.; Trimeris Inc.
An Open-Label Study Assessing the Safety and Tolerability of Chronic Dosing with a New Fusion Inhibitor in HIV Positive Subjects Who Have Failed Therapy with a Fusion Inhibitor Containing Regimen
Principal Investigator: Harold Martin, MD
Sponsor: Trimeris Inc.
A Phase I/II Trial to Evaluate the Safety and Antiviral Activity of a New Fusion Inhibitor in HIV-1 Infected Adults Who Have Failed Treatment with their Current Fusion Inhibitor and Background Antiretroviral Therapy
Principal Investigator: Harold Martin, MD
Sponsor: Hoffman-LaRoche Inc.
A Rollover Study of a New Fusion Inhibitor Administered in Combination with a Background Antiretroviral Regimen in HIV-1 Adults Who have Completed a Clinical Trial with the New Infusion Inhibitor
Principal Investigator: Harold Martin, MD
Sponsor: Hoffman-LaRoche Inc.
A Phase IV, Open-Label, Multicenter Study of a Combination of Antiretroviral drugs in HIV-Infected Subjects Experiencing Early Virologic Failure
Principal Investigator: Harold Martin, MD
Sponsor: GlaxoSmithKline
Back
International Diabetes Center
The Effect a New Medication on Albuminuria in Patients with Type 2 Diabetes
Principal Investigator: Richard Bergenstal, MD
Sponsor: Eli Lilly and Company
A New Medication Treatment of Peripheral Neuropathy in Patients with Diabetes: A Phase III Pivotal Trial
Principal Investigator: Richard Bergenstal, MD
Sponsor: Eli Lilly and Company
A New Medication Treatment for Symptomatic Peripheral Neuropathy in Patients with Diabetes
Principal Investigator: Richard Bergenstal, MD
Sponsor: Eli Lilly and Company
Evaluation of Interstitial Fluid Glucose Monitoring with the TheraSense Continuous Monitoring System
Principal Investigator: David Kendall, MD
Sponsor: TheraSense Inc.
Device to Measure Hemoglobin A1c Clinical Trial Protocol #4
Principal Investigator: Richard Bergenstal, MD
Sponsor: Metrika, Inc.
An Open-Label Extension Study of Protocol 2993-115 to Examine the Long-Term Effect on Glucose Control (HbA1c) and Safety and Tolerability of a New Medication Given Two Times a Day to Subjects Treated with Metformin and a Sulfonylurea
Principal Investigator: David Kendall, MD
Sponsor: Amylin
Morning Long-Acting Insulin versus Intermediate-Acting Insulin Twice Daily as Basal Insulin in a Multiple Daily Injection Regimen with Rapid-Acting Insulin in Adolescents with Type 1 Diabetes Mellitus: An Active-Controlled, Open, Randomized, Gender-Stratified, Two-Arm, Parallel-Group Study
Principal Investigator: Martha Spencer, MD
Sponsor: Aventis Pharmaceuticals
Efficacy and Safety of a New Insulin Compared to Placebo in Patients with Type 2 Diabetes Mellitus Following Diabetes Education
Principal Investigator: Richard Bergenstal, MD
Sponsor: Pharmaceutical Discovery Corporation
Driving Safety and Diabetes
Principal Investigator: Roger Mazze, PhD
Sponsor: National Institutes of Health
New Blood Glucose Meter System Evaluation Patient Use Protocol
Principal Investigator: David Kendall, MD
Sponsor: Bayer Corporation
The ANSWER Program: The Norditropin National Registry Program
Principal Investigator: Martha Spencer, MD
Sponsor: PharmaMar
Basal/Bolus Therapy with Rapid-Acting Insulin versus Short-Acting Insulin, or Rapid-Acting Insulin in Combination with Intermediate-Acting Insulin: Open-Label, Randomized, Parallel-Group, Multicenter Study in Children and Adolescents with Type 1 Diabetes
Principal Investigator: Martha Spencer, MD
Sponsor: Novo Nordisk Pharmaceuticals Inc.
Field Evaluation of the a New Glucose Test Strip for MediSense Blood Glucose Monitoring Systems--Accuracy, Lay-User Acceptability and Precision
Principal Investigator: Richard Bergenstal, MD
Sponsor: Abbott Laboratories Inc.
Field Evaluation of a New Point of Care System, Intended User
Principal Investigator: Richard Bergenstal, MD
Sponsor: Abbott Laboratories Inc.
Home Testing of a New Blood Glucose Monitoring System by Lay Users
Principal Investigator: Richard Bergenstal, MD
Sponsor: Abbott Laboratories Inc.
Clinical Code Verification of a New Blood Glucose Monitoring System
Principal Investigator: Dawn Bina, MT, ASCP
Sponsor: Hypoguard USA Inc.
Clinical Evaluation of a New Blood Glucose Monitoring System
Principal Investigator: Dawn Bina, MT, ASCP
Sponsor: Hypoguard USA Inc.
Blood Glucose Meter Software Consumer Evaluation
Principal Investigator: Dawn Bina, MT, ASCP
Sponsor: Hypoguard USA Inc.
New Blood Glucose Meter Evaluation
Principal Investigator: David Kendall, MD
Sponsor: Bayer Corporation
A New Medication in Type 2 Hypertriglyceridemic Diabetic Subjects: A Twenty-Six-Week Double-Blind, Multicenter, Randomized, Parallel, Active-Controlled Study to Investigate Safety and Efficacy
Principal Investigator: Gregory Damberg, MD
Sponsor: Novo Nordisk Pharmaceuticals Inc.
Central Obesity and Elevated Albumin Excretion in Type 1 Diabetes
Principal Investigator: Richard Bergenstal, MD
Sponsor: National Institutes of Health
Diabetes Coaching at the Worksite
Principal Investigator: Lorraine Schafer, PhD
Sponsor: Park Nicollet Foundation; Park Nicollet Institute
Collaborative Care Model for Diabetes in the School Setting
Principal Investigator: Lorraine Schafer, PhD
Sponsor: Park Nicollet Foundation
Program Evaluation: Measuring the Effectiveness of Intensive Insulin Therapy through Multiple Daily Injections and a Continuous Subcutaneous Insulin Infusion Diabetes Management Program
Principal Investigator: Lisa Fish, MD
Sponsor: Disetronic Medical Systems Inc.; Eli Lilly and Company
Smoking Cessation in Adults with Type 2 Diabetes
Principal Investigator: David Kendall, MD
Sponsor: Minnesota Partnership for Action Against Tobacco (MPAAT)
A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients with Drug-Naïve, Recently Diagnosed Type 2 Diabetes Mellitus (<2 years)
Principal Investigator: Gregory Damberg, MD
Sponsor: GlaxoSmithKline
Concentration Control Trial of Norditropin® SimpleXx™ in Children with Growth Hormone Deficiency: A Two-Year, Open-Label, Randomized, Multicenter Trial
Principal Investigator: Martha Spencer, MD
Sponsor: Novo Nordisk Pharmaceuticals Inc.
Pioglitazone Versus Rosiglitazone in Subjects with Type 2 Diabetes Mellitus and Dyslipidemia
Principal Investigator: David Kendall, MD
Sponsor: Eli Lilly and Company
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Principal Investigator: David Kendall, MD
Sponsor: National Institutes of Health
Action to Control Cardiovascular Risk in Diabetes: Coronary Artery Calcium Pilot Study ACCORD (CAC)
Principal Investigator: David Kendall, MD
Sponsor: National Institutes of Health
The DREAM (Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication) Trial
Principal Investigator: Richard Bergenstal, MD
Sponsors: Canadian Institutes of Health Research; Aventis Pharmaceuticals; King Pharmaceuticals; GlaxoSmithKline
Genetic Studies of Diabetic Complications in Epidemiology of Diabetes Interventions and Complications
Principal Investigator: Richard Bergenstal, MD
Sponsor: National Institutes of Health
A Market Research Study of a New Device for Use to Detect Trends and Track Patterns in Glucose Levels in Adult Patients with Diabetes
Principal Investigator: David Kendall, MD
Sponsor: Cygnus Inc.
A Randomized, Double-Blind, Multicenter Study Comparing the Glycemic Control Characteristics of Two Antihypertensive Drugs in Hypertensive Patients with Type 2 Diabetes Mellitus
Principal Investigator: C. Rowan DeBold, MD
Sponsor: GlaxoSmithKline
Evaluation of the Dose-Response Relationship of a New Drug on Fasting and Postprandial Blood Glucose and Tolerability in Patients with Type 2 Diabetes
Principal Investigator: Richard Bergenstal, MD
Sponsor: Eli Lilly and Company
A 12-Week, Multinational, Multicenter, Controlled, Open, 1:1:1 Randomized, Parallel Clinical Trial to Assess Non-Inferiority Between Pre and Post-Meal Administration of a New Rapid-Acting Insulin and Pre-Meal Regular Human Insulin in Subjects with Type 1 Diabetes Mellitus Receiving Long-Acting Insulin as the Basal Insulin Therapy
Principal Investigator: Richard Bergenstal, MD
Sponsor: Aventis Pharmaceuticals
Evaluation of Blood Glucose Concentrations Using a New Blood Glucose Monitoring System at Alternate Testing Sites Relative to Intrinsic Values
Principal Investigator: David Kendall, MD
Sponsor: LifeScan Inc.
A Multicenter, Randomized, Open-Label, Crossover Trial in Insulin-Requiring Type1 Subjects with Diabetes: Preference and Frequency of Blood Glucose Monitoring Comparison with Combined Insulin Pen/Meter and Vial/Syringe/Separate Meter
Principal Investigator: Richard Bergenstal, MD
Sponsor: Novo Nordisk Pharmaceuticals Inc.
A New Drug in Type 2 Diabetic Subjects: A Fifty-Two-Week Double-Blind, Parallel, Active-Controlled (Diabetra® and Glucophage®) Study (Followed by a Fifty-Two-Week, Open-Label Extension) to Investigate Safety and Efficacy
Principal Investigator: David Kendall, MD
Sponsor: Novo Nordisk Pharmaceuticals Inc.
Field Evaluation of a New Blood Glucose Monitoring System: Accuracy, Lay User Acceptability and Precision
Principal Investigator: Richard Bergenstal, MD
Sponsor: Abbott Laboratories Inc.
A Clinical Feasibility Study of a New Blood Glucose Monitoring System when Used with Capillary and Venous Blood Samples in the Hands of Health Care Professionals and Lay Users
Principal Investigator: David Kendall, MD
Sponsor: LifeScan Inc.
Diabetes Prevention Trial: Type 1 (DPT-1)
Principal Investigator: Martha Spencer, MD
Sponsor: National Institutes of Health
A Two-Year Study to Test the Ability of a New Device to Detect Diabetes Early by Using a Special Light to Measure the Sugar Level in the Eye and Comparing This to Current Methods of Detecting by Blood Tests
Principal Investigator: Richard Bergenstal, MD
Sponsor: Roche Diagnostics
Program Evaluation: Measuring the Effectiveness of Intensive Insulin Therapy through Multiple Daily Injections and a Continuous Subcutaneous Insulin Infusion Diabetes Management Program (AIM)
Principal Investigator: Lisa Fish, MD
Sponsors: Disetronic Medical Systems Inc.; Eli Lilly and Company; Roche Diagnostics
Smoking Cessation in Adults with Type 2 Diabetes
Principal Investigator: David Kendall, MD
Sponsor: Minnesota Partnership for Action Against Tobacco (MPAAT)
Back
Neurology
Carotid Occlusion Surgery Study
Principal Investigator: Sandra Hanson, MD
Sponsor: National Institute of Neurological Disorders and Stroke
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Tolerability of an Oral Medication for a Single, Moderate or Severe Headache in Adults Diagnosed with Migrainous Disorder
Principal Investigator: Frederick Taylor, MD
Sponsor: GlaxoSmithKline
A Muticenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Trial to Evaluate Early Efficacy and Tolerability of a New Nasal Spray in the Acute Treatment of Adult Subjects With Migraine
Principal Investigator: Frederick Taylor, MD
Sponsor: AstraZeneca LP
Improving Utilization of Ischemic Stroke Research
Principal Investigator: Catherine Borbas, PhD, MPH, Healthcare Education and Research Foundation Inc.
Sponsor: Agency for Healthcare Research and Quality
American Academy of Neurology Stoke Practice Improvement Network (SPIN)
Principal Investigator: John Davenport, MD
Sponsor: American Academy of Neurology
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Single-Attack Study of a New Medication in the Treatment of Moderate to Severe Migraine Present Upon Awakening
Principal Investigator: Frederick Taylor, MD
Sponsor: GlaxoSmithKline
Stroke Treatment in the Community II
Principal Investigator: Sandra Hanson, MD
Sponsor: Park Nicollet Institute
Obstetrics and Gynecology
Somali Childbirth Education Initiative
Principal Investigator: Deb Thorp, MD
Sponsor: Park Nicollet Foundation; Celebration for Life; Private Donation
Helicobacter Pylori Infection and Hyperemesis Gracidarum in Women from Somalia
Principal Investigator: Susan Feron, MD, University of Minnesota
Sponsor: University of Minnesota
Treatment of Overactive Bladder with Botulinum Toxin B: A Pilot Study
Principal Investigator: Albert Enriquez, MD
Sponsor: Elan Corporation
Occupational Health/Health Source
Effectiveness of a Machine Guarding Intervention
Principal Investigator: David Parker, MD
Sponsor: Centers for Disease Control and Prevention
Occupational Health/Oncology Research
Evaluation of a Tobacco Cessation Program for Employees at Park Nicollet Health Services
Principal Investigators: Kari Olson-Finnegan, RN; Karen Swenson, RN, MS, AOCN; Jan Kjellberg, RN
Sponsor: Park Nicollet Health Services
Back
Oncology Research
A Study to Assess Symptom Burden in Subjects with Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp™
Principal Investigator: Martin Lee, MD
Sponsor: Amgen Inc.
A Phase I Dose-Escalation Study of Thrice-Weekly New Medication in Combination with Trastuzumab in Subjects with HER-2/neu Positive Metastatic Breast Cancer
Principal Investigator: Martin Lee, MD
Sponsor: Chiron Therapeutics
A Multicenter, Open-Label Trial to Evaluate the Efficacy and Safety of a New Radioimmunotherapy of Relapsed or Refractory Low-Grade or Follicular Transformed B-Cell Non-Hodgkin's Lymphoma
Principal Investigator: Martin Lee, MD
Sponsor: IDEC Pharmaceuticals Corporation
A Randomized, Open-Label, Multicenter Study of Primary Prophylaxis with Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis as an Adjunct to Chemotherapy in Elderly Subjects (³65y.o.) with Cancer
Principal Investigator: Martin Lee, MD
Sponsor: Amgen Inc.
Assessing the Burden of Chemotherapy Side Effects in Patients Who Have Experienced Side Effects and Nurses Who Care for This Patient Population
Principal Investigator: Karen Swenson, RN, MS, AOCN
Sponsor: Amgen Inc.
Dietary Intake in Women with Breast Cancer: Study 1: Comparison to National Data Sets; Study 2: Predictors to Adherence to a Low-Fat Diet Intervention
Principal Investigator: Alice Shapiro, PhD, RD, LN
Sponsor: Park Nicollet Institute
A Prognostic Study of Sentinel Node and Bone Marrow Micrometastases in Women with Clinical Stage T1 or T2 Breast Cancer
Principal Investigator: Joel Friedman, MD
Sponsor: American College of Surgeons
A Randomized Trial of Axillary Node Dissection in Women With Clinical Stage T1 or T2 N0M Breast Cancer Who Have a Positive Sentinel Node
Principal Investigator: Joel Friedman, MD
Sponsor: American College of Surgeons
Breast Cancer Risk Factors and Diagnostic Mammogram Sensitivity Among Women Diagnosed with Breast Cancer in Their Forties
Principal Investigator: Carol McPherson, MSW, MPH
Sponsor: Park Nicollet Institute
Complication Rate for Sentinel Lymph Node Biopsy: Ancillary Study to Sentinel Lymph Node Biopsy for Patients with Breast Cancer
Principal Investigator: Karen Swenson, RN, MS, AOCN
Sponsor: Park Nicollet Institute
Illness Attributes and Predictors of Well-Being in Younger Women with Breast Cancer
Principal Investigator: Elizabeth Kraatz
Sponsor: University of Minnesota
Breast Cancer Adjuvant Educational Program (BCAEP): A Randomized Clinical Trial of a Computer-Based Learning Tool to Aid in Decision-Making Concerning Adjuvant Therapy for Early Breast Cancer
Principal Investigator: Martin Lee, MD
Sponsor: Park Nicollet Institute
A Multicenter Clinical Trial to Determine the Efficacy of a Dietary Fat Reduction Program Provided in Addition to Systemic Adjuvant Therapy in the Management of Patients with Primary Invasive Breast Cancer
Principal Investigator: Alice Shapiro, PhD
Sponsor: American Health Foundation
Sunbelt Melanoma Trial (SMT): A Multicenter Trial of Adjuvant Interferon Alfa-2b for Melanoma Patients with Early Lymph Node Metastasis Detected by Lymphatic Mapping and Sentinel Lymph Node Biopsy
Principal Investigator: Keith Heaton, MD
Sponsor: Schering Corporation
A Prospective Study to Compare Side Effects and Functional Status by Treatment Type for Early Stage Prostate Cancer
Principal Investigator: Carol McPherson, MSW, MPH
Sponsor: Nycomed-Amersham
An Expanded Access Clinical Program with a New Medication for Patients with Advanced Non-Small Cell Lung Cancer
Principal Investigator: Joseph Leach, MD
Sponsor: AstraZeneca LP
Interleukin-2 in an Alternative Dose (ILIAD Trial): Treatment of Patients with Metastatic Renal Cell Carcinoma with Low-Dose Proleukin
Principal Investigator: Martin Lee, MD
Sponsor: Chiron Therapeutics
Phase I/II Clinical Trial of a Combination of Weekly Vinorelbine and Weekly Carboplatin in Advanced Non-Small Cell Lung Cancer
Principal Investigator: Martin Lee, MD
Sponosr: GlaxoSmithKline
A Pilot Study of a Combination of Mitoxantrone, Estramustine, Weekly Paclitaxel (Taxol) and Hydrocortisone (METH) for the Treatment of Hormone-Resistant Prostate Cancer
Principal Investigator: Martin Lee, MD
Sponsor: Bristol-Myers Squibb Company
A Controlled, Randomized, Phase III Trial Comparing the Response to Dacarbazine with and without a New Medication in Patients with Metastatic Melanoma
Principal Investigator: Martin Lee, MD
Sponsor: Vical Inc.
Extended Treatment Protocol for a New Immunotherapy in Metastatic Cancer by Direct Gene Transfer
Principal Investigator: Martin Lee, MD
Sponsor: Vical Inc.
Feasibility of a Daily Diary to Characterize Symptoms of Breast Cancer Patients in an Outpatient Setting
Principal Investigator: Robin Lally, RN, MS, OCN
Sponsor: Park Nicollet Jane Brattain Breast Center
Phase II Multicenter Study of a New Medication in Patients with Metastatic Colorectal Carcinoma
Principal Investigator: Martin Lee, MD
Sponsor: ImClone
Helping the Mother with Breast Cancer Support Her Child
Principal Investigator: Janice Post-White, RN, PhD, FAAN, University of Minnesota
Sponsor: National Cancer Institute
A Randomized Clinical Study to Determine the Patient Benefit of a New Medication for the Treatment of Neoplastic Meningitis
Principal Investigator: Martin Lee, MD
Sponsor: SkyePharma Inc.
An Open-Label, Randomized Study to Develop a Screening Tool for Functional Capacity in Anemic Subjects with Nonmyeloid Malignancies Receiving Chemotherapy and NESP
Principal Investigator: Martin Lee, MD
Sponsor: Amgen Inc.
Back
Oncology Research/Surgery
Intraoperative Subareolar Injection of Technetium-99 for Breast Sentinel Lymph Node Identification
Principal Investigator: Joel Friedman, MD
Sponsor: Park Nicollet Institute
Orthopedics
Muscle Incursion in Carpal Tunnel Syndrome: A Magnetic Resonance Imaging Study
Principal Investigator: Benjamin Levine, MD
Sponsor: Park Nicollet Institute
A Double-Blind, Randomized, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of a New Peptide Drug on the Rate of Healing in Distal Radius Fractures
Principal Investigator: Benjamin Levine, MD
Sponsor: Orthologic
Pathology
Validation of Plasma D-Dimer Methods in the Evaluation of Venous Thromboembolism
Principal Investigator: Timothy Miley, MD
Sponsor: Park Nicollet Institute
Pediatrics
Synagis Outcomes Registry
Principal Investigator: Andrew Rzepka, MD
Sponsor: MedImmune Inc.
Commercial Photography/Strabismus-Screening Study
Principal Investigators: Albert Yonas, PhD, University of Minnesota; Stephen Christianson, MD, University of Minnesota
Sponsor: University of Minnesota
Pulmonary
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Assess the Long-Term Efficacy of a New Oral Medication in the Treatment of Narcolepsy
Principal Investigator: Salim Kathawalla, MD
Sponsor: Orphan Medical Inc.
Radiology
Second Look Work-Up Rate Evaluation
Principal Investigator: Michael Nelson, MD
Sponsor: CADXCADx Medical Systems Inc.
Computer-Aided Detection of Mammograms
Principal Investigator: Michael T. Nelson, MD
Sponsor: ICAD Inc.
Radiology/Oncology Research
Lobular Carcinoma In Situ and Atypical Lobular Hyperplasia at Percutaneous Biopsy with Surgical Correlation: A Multi-Institutional Study
Principal Investigator: Mary Lechner, MD
Sponsor: Park Nicollet Institute
Back
Rheumatology Treatment and Resource Center
A Randomized, Multicenter, Parallel-Group Study to Determine if Knowledge of Baseline Vertebral Fracture Prevalence (as Determined by Hologic IVA) and Bone Turnover Marker Levels Improves Persistence with Actonel 5 MG. Daily Therapy in Subjects Receiving Chronic Glucocorticoid Therapy
Principal Investigator: John Schousboe, MD
Sponsor: Aventis Pharmaceuticals
Comparison of the Effects of Two Individual Osteoporosis Medications on Lumbar Spine Bone Mineral Density in Glucocorteroid-Induced Osteoporosis
Principal Investigator: John Schousboe, MD
Sponsor: Eli Lilly and Company
A Phase III, Randomized, Multicenter Study Comparing the Safety and Efficacy of a New Gout Medication Versus Allopurinol in Subjects with Gout
Principal Investigator: Scott Glickstein, MD
Sponsor: TAP Pharmaceuticals Inc.
BioMarkers for Anti-TNF Response in Rheumatoid Arthritis
Principal Investigator: Eric Schned, MD
Sponsor: National Institutes of Health
Phase III Randomized, Double-Blind, Placebo-Controlled Study of an Anti-TNF Inhibitor Administered SC Once-Weekly in Patients with Active Rheumatoid Arthritis
Principal Investigator: Scott Glickstein, MD
Sponsor: Amgen Inc.
A Study of the Agreement between the Standard and Modified ACR Improvement Criteria in Rheumatoid Arthritis Subjects Receiving Kineret (Anakinra) After Having an Unsatisfactory Response to Disease-Modifying Anti-Rheumatic Drug Therapy (DMARDS) or KOMET (Kineret Outcome Measurements Evaluation with Treatment)
Principal Investigator: Robert Tierney, MD
Sponsor: Amgen Inc.
Accuracy of Lateral X-ray Absorptiometry to Detect Vertebral Compression Fracture Deformities Compared to Standard Radiography, and Impact of their Detection on Therapy to Prevent Osteoporotic Fracture
Principal Investigator: John Schousboe, MD
Sponsor: Hologic; Park Nicollet Institute
Osteoporosis Education and Screening in the Community: Effect on Health Care Behavior with Respect to Preventing Osteoporosis in Employed Populations
Principal Investigator: John Schousboe, MD
Sponsor: Park Nicollet Foundation
SONORA: Study of New-Onset Rheumatoid Arthritis
Principal Investigator: Robert Tierney, MD
Sponsor: Abbott Laboratories Inc.
Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT)
Principal Investigator: John Schousboe, MD
Sponsor: Rheumatoid Arthritis Investigational Network
Can Patients Self-Select Themselves for Bone Densitometry? Utility of the Osteoporosis Risk Assessment Instrument (ORAI) Mailed to Women Age 45 and Older
Principal Investigator: John Schousboe, MD
Sponsor: Park Nicollet Foundation
Treatment of Early Rheumatoid Arthritis: Minocycline in Combination with Methotrexate Versus Methotrexate Alone
Principal Investigator: John Schousboe, MD
Sponsor: Rheumatoid Arthritis Investigational Network
Triple III: Comparison of Leflunomide Alone Versus Two Disease-Modifying Anti-Rheumatic Drug (DMARD) Combinations (Leflunomide-Hydroxychloroquine-Sulfasalazine or Methotrexate-Hydroxychloroquine-Sulfasalazine) in the Treatment of Rheumatoid Arthritis
Principal Investigator: John Schousboe, MD
Sponsor: Rheumatoid Arthritis Investigational Network
An International, Multicenter, Stratified, Randomized, Double-Blind, Double-Dummy, Parallel-Group, 52-Week Gastrointestinal Clinical Safety Study to Demonstrate that a new COX II Inhibitor Reduces the Risk to Develop Complicated Ulcers as Compared to Naproxen (500mg. BID), in Rheumatoid Arthritis and Osteoarthritis Patients
Principal Investigator: Carolyn Bowles, MD
Sponsor: Novartis Pharmaceuticals
Treatment of Early Rheumatoid Arthritis: The Role of Doxycycline in Combination with Methotrexate
Principal Investigator: John Schousboe, MD
Sponsor: Rheumatoid Arthritis Investigational Network
A Six-Month, Open-Label Safety Trial of Enbrel (etanercept) plus Hydroxychloroquine, Sulfasalazine, or Injectable Gold in Patients with Rheumatoid Arthritis
Principal Investigator: John Schousboe, MD
Sponsor: Rheumatoid Arthritis Investigational Network
Sexual Health
Evaluation of the Use of a Unique Topical Gel Formulation in Males with a Testosterone Level 300/dL
Principal Investigator: William Borkon, MD
Sponsor: Auxilium Pharmaceuticals Inc.
A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy, Safety, and Toleration of an Oral Medication Administered for 12 Weeks to Post-Menopausal Women Who Have Been Diagnosed with Female Sexual Arousal Disorder
Principal Investigator: Willliam Borkon, MD
Sponsor: Pfizer Inc.
A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy, Safety, and Toleration of an Oral Medication Administered for 12 Weeks to Pre-Menopausal Women Who Have Been Diagnosed with Female Sexual Arousal Disorder
Principal Investigator: Willliam Borkon, MD
Sponsor: Pfizer Inc.
Struthers Parkinson's Center
A 12-Week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study of the Efficacy of a New Medication as Treatment for Parkinson’s Disease in Patients with Motor Response Complications on Levodopa/Carbidopa Therapy
Principal Investigator: Sotirois Parashos, MD
Sponsor: Lineberry Research Associates
A Long-Term, Multicenter, Open-Label Safety Study with a Flexible-Dose Range of a New Medication as Treatment for Parkinson’s Disease in Patients with Motor Response Complications on Levodopa/Carbidopa Therapy
Principal Investigator: Sotirois Parashos, MD
Sponsor: Lineberry Research Associates
A Prospective, Randomized, Placebo-Controlled, Parallel-Group Study of the Continued Efficacy and Safety of Subcutaneous Injections of Apomorphine in the Treatment of "Off" Episodes in Patients with "On/Off" or "Wearing-Off" Effects Associated with Late-Stage Parkinson's Disease after Apomorphine Use for at least a Three-Month Duration
Principal Investigator: Martha Nance, MD
Sponsor: Mylan Pharmaceuticals
Optimizing Therapeutic Outcome with Comtan in Parkinson’s Disease Patients
Principal Investigator: Catherine Wielinski, MPH
Sponsor: Novartis Pharmaceuticals
Plasma Half-Life of Levodopa after Administration of Additional Carbidopa in PD Patients Already Treated with a Combination of Carbidopa/Levodopa and Entacapone
Principal Investigator: Sotirois Parashos, MD
Sponsor: Struthers Parkinson’s Center
Back
Publications 2002
This page links to the full publications list
Asthma and Allergy
Graft DF. Maintenance venom immunotherapy. Current Opinion in Allergy and Clinical Immunology 2002;2(4):359-362.
Schoenwetter WF, Gupta N, Liu J, Van As A. Omalizumab, an anti-immunoglobin E antibody, is well-tolerated in patients with allergic diseases of the airways. Chest 2002;122(4 Suppl):85.
Schoenwetter WF, Sveum RJ. Anticholinergic agents, Guaifenesin, and decongestants in the treatment of rhinitis. In: Kaliner MA, editor. Current review of rhinitis. Philadelphia: Current Medicine, Inc.; 2002. p. 175-177.
Sveum RJ. Asthma guidelines revisited [CME audiocassette/CD]. Audio-Digest Otolaryngology 2002;35(22).
Sveum RJ. Additive drug for asthma [CME audiocassette/CD]. Audio-Digest Otolaryngology 2002;35(22).
Family Practice
McPherson CP, Swenson KK, Pine DA, Leimer L. A nurse-based pilot program to reduce cardiovascular risk factors in a primary care setting. American Journal of Managed Care 2002;8(6):543-555.
Olson KP. "Oh, by the way...": agenda setting in office visits. Family Practice Management 2002;9(10):63-64.
Von Weiss D. Use of mindfulness meditation for fibromyalgia [letter to editor]. American Family Physician 2002;65(3):380.
Back
Gastroenterology
Bleau BL, Gostout CJ, Sherman KE, Shaw MJ, Harford WV, Keate RF, Bracy WP, Fleischer DE. Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy. Gastrointestinal Endoscopy 2002;56(1):1-6.
Health Policy
Cassirer C, Anderson D, Hanson AS. Abusive behavior in the healthcare workplace. Creative Nursing 2002;8(2):8-9.
Fowles J, Kind EA, Braun BL. Employee responses when their employer moved to a defined contribution plan [Conference proceeding from Academy for Health Services Research and Health Policy Annual Research Meeting, June 2002: Abstract published online] 2002 AcademyHealth.
Fowles J, Kind AC, Kind EA, Mandel J, Adlis S. Which patients want to look at their medical record and why? [Conference proceeding from Academy for Health Services Research and Health Policy Annual Research Meeting, June 2002: Abstract published online] 2003 AcademyHealth.
Knutson D, Fowles JB, Kind EA. The impact of health-based risk adjusted payment on health plans [Conference proceeding from Academy for Health Services Research and Health Policy Annual Research Meeting, June 2002: Abstract published online] 2002 AcademyHealth.
Koering SM. A cancer program's seal of approval. Journal of the American Health Information Management Association 2002;73(1):40-44.
Terry PE. Innovation in disease management. Managed Care 2002;11(9 Suppl):23-26.
Braun BL, Kind EA, Fowles JB, Suarez WG. Consumer response to a report card comparing healthcare systems. American Journal of Managed Care 2002;8(6):522-528.
Infectious Disease
Suntharam N, Lankford MG, Trick WE, Peterson LR, Noskin GA. Risk factors for acquisition of vancomycin-resistant enterococci among hematology-oncology patients. Diagnostic Microbiology and Infectious Disease 2002;43(3):183-188.
Back
International Diabetes Center
Franz MJ, Reader D, Monk A. Implementing Group and Individual Medical Nutrition Therapy for Diabetes. Alexandria, VA: American Diabetes Association; 2002.
Grundy SM, Vega GL, McGovern ME, Tulloch BR, Kendall DM, Fitz-Patrick D, Ganda OP, Rosenson RS, Buse JB, Robertson DD, et al. Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial. Archives of Internal Medicine 2002;162(14):1568-1576.
Mazze R, Robinson R, Simonson G, Gerken S, Sundem S, Spencer M, Idrogo M, Strock E, Bergenstal R, Etzweiler D et al. Detection and Treatment of Metabolic Syndrome and Type 2 Diabetes in Children and Adolescents. 1st ed. Minneapolis: International Diabetes Center; 2002.
Mazze RS. Measuring and managing hyperglycemia in pregnancy: from glycosuria to continuous blood glucose monitoring. Seminars in Perinatology 2002;26(3):171-180.
Reader DM, O'Connell BS, Johnson ML, Franz M. Glycemic and insulinemic response of subjects with type 2 diabetes after consumption of three energy bars. Journal of the American Dietetic Association 2002;102(8):1139-1142.
Rickheim PL, Weaver TW, Flader JL, Kendall DM. Assessment of group versus individual diabetes education: a randomized study. Diabetes Care 2002;25(2):269-274.
Semakula C, Pambuccian S, Gruessner R, Kendall DM, Pittenger G, Vinik A, Seaquist ER. Clinical case seminar: hypoglycemia after pancreas transplantation: association with allograft nesidiodysplasia and expression of islet neogenesis-associated peptide. Journal of Clinical Endocrinology and Metabolism 2002;87(8):3548-3554.
Neurology
Hanson SK, Brauer DJ, Brown RD, Anderson DC, Altafullah IM, Davenport JG, Ramirez-Lassepas M, Adlis S. Minnesota community experience with intravenous rt-PA for acute ischemic stroke: Stroke Treatment in the Community Study (STIC) [abstract]. Stroke 2002;33:387.
Lazovich D, Murray DM, Brosseau LM, Parker DL, Milton FT, Dugan SK. Sample size considerations for studies of intervention efficacy in the occupational setting. Annals of Occupational Hygiene 2002;46(2):219-227.
Li YJ, Scott WK, Hedges DJ, Zhang F, Gaskell PC, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, et al. Age at onset in two common neurodegenerative diseases is genetically controlled. American Journal of Human Genetics 2002;70(4):985-993.
Mao R, Aylsworth AS, Potter N, Wilson WG, Breningstall G, Wick MJ, Babovic-Vuksanovic D, Nance M, Patterson MC, Gomez CM, et al. Childhood-onset ataxia: testing for large CAG-repeats in SCA2 and SCA7. American Journal of Medical Genetics 2002;110(4):338-345.
Nance MA. Predictive and prenatal testing for late-onset neurodegenerative disorders in North America. In: Evers-Kiebooms G, Zoeteweij M, Harper P, editors. Prenatal testing for late onset neurodegenerative diseases. Oxford UK: Bios Publishers; 2002. p. 191-201.
Nance MA, Westphal B. Comprehensive care in Huntington's disease. In: Harper PS, editor. Huntington's disease. Oxford, UK: Oxford University Press; 2002. p. 475-500.
Tanne D, Kasner SE, Demchuk AM, Koren-Morag N, Hanson S, Grond M, Levine SR, and the Multicenter tPA Stroke Survey Group. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice; the Multicentr rt-PA Acute Stroke Survey. Circulation 2002;105:1679-1685.
Back
Occupational Rehabilitation
Brosseau LM, Parker DL, Lazovich D, Milton T, Dugan S. Designing intervention effectiveness studies for occupational health and safety: the Minnesota wood dust study. American Journal of Industrial Medicine 2002;41(1):54-61.
Callinan N. Construction of hand splints. In: Trombley CA, Radomski MV, editors. Occupational therapy for physical dysfunction. Philadelphia: Lippincott Williams & Wilkins; 2003. p. 351-370.
Lazovich D, Parker DL, Brosseau LM, Milton FT, Dugan SK, Pan W, Hock L. Effectiveness of a worksite intervention to reduce an occupational exposure: the Minnesota wood dust study. American Journal of Public Health 2002;92(9):1498-1505.
McGrail MP, Jr., Calasanz M, Christianson J, Cortez C, Dowd B, Gorman R, Lohman WH, Parker DL, Radosevich DM, Westman G. The Minnesota Health Partnership and coordinated health care and disability prevention: the implementation of an integrated benefits and medical care model. Journal of Occupational Rehabilitation 2002;12(1):43-54.
Munshi K, Parker DL, Bannerman-Thompson H, Merchant D. Causes, nature, and outcomes of work-related injuries to adolescents working at farm and non-farm jobs in rural Minnesota. American Journal of Industrial Medicine 2002;42(2):142-149.
Parker DL. Street children and child labour around the world. Lancet 2002;360(9350):2067-2071.
Parker DL, Merchant D, Munshi K. Adolescent work patterns and work-related injury incidence in rural Minnesota. American Journal of Industrial Medicine 2002;42(2):134-141.
Parker DL, Bachman S. Economic exploitation and the health of children: towards a public health model. Health and Human Rights 2002;5:93-119.
Parker DL. By these hands: portraits from the factory floor. St. Paul: Minnesota Historical Society Press; 2002.
Oncology Research
Brundage D, Peterson K, Jordan J. Evaluation of an acute pain initiative in a community teaching hospital [abstract]. Pharmacotherapy 2002;22(10):1373.
Chelf JH, Deshler AM, Thiemann KM, Dose AM, Quella SK, Hillman S. Learning and support preferences of adult patients with cancer at a comprehensive cancer center. Oncology Nursing Forum 2002;29(5):863-867.
McPherson CP, Swenson KK, Lee MW. The effects of mammographic detection and comorbidity on the survival of older women with breast cancer. Journal of the American Geriatric Society 2002;50(6):1061-1068.
McPherson CP, Nissen MJ. Evaluating a risk-based model for mammographic screening of women in their forties. Cancer 2002;94(11):2830-2835.
Nissen MJ, Swenson KK, Kind EA. Quality of life after postmastectomy breast reconstruction. Oncology Nursing Forum 2002;29(3):547-553.
Swenson KK, Nissen MJ, Ceronsky C, Swenson L, Lee MW, Tuttle TM. Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Annals of Surgical Oncology 2002;9(8):745-753.
Swenson KK. Hospital stay is a teachable moment for tobacco cessation [letter to editor]. Clinical Journal of Oncology Nursing 2002;6(2):71.
Tuttle TM, Colbert M, Christensen R, Ose KJ, Jones T, Wetherille R, Friedman J, Swenson KK, McMasters KM. Subareolar injection of 99mTc facilitates sentinel lymph node identification. Annals of Surgical Oncology 2002;9(1):77-81.
Tuttle TM, Zogakis TG, Dunst CM, Zera RT, Singletary SE. A review of technical aspects of sentinel lymph node identification for breast cancer. Journal of the American College of Surgeons 2002;195(2):261-268.
Wong SL, Edwards MJ, Chao C, Tuttle TM, Noyes RD, Carlson DJ, Laidley AL, McGlothin TQ, Ley PB, Brown CM, et al. The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Annals of Surgical Oncology 2002;9(3):272-277.
Wong SL, Chao C, Edwards MJ, Carlson DJ, Laidley A, Noyes RD, McGlothin T, Ley PB, Tuttle TM, Schadt M, et al. Frequency of sentinel lymph node metastases in patients with favorable breast cancer histologic subtypes. American Journal of Surgery 2002;184(6):492-498.
Wong SL, Edwards MJ, Chao C, Tuttle TM, Noyes RD, Carlson DJ, Laidley AL, McGlothin TQ, Ley PB, Brown CM, et al. The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Annals of Surgical Oncology 2002;9(3):272-277.
Back
Pediatrics
Kahn WK, Belani KK. Index of suspicion. Pediatrics in Review 2002;23(4):141-146.
Radiation Therapy
Sneed PK, Suh JH, Goetsch SJ, Sanghavi SN, Chappell R, Buatti JM, Regine WF, Weltman E, King VJ, Breneman JC, et al. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. International Journal of Radiation Oncology Biology Physics 2002;53(3):519-526.
Rheumatology Treatment and Resource Center
Hoffman GS, Cid MC, Hellmann DB, Guillevin L, Stone JH, Schousboe J, Cohen P, Calabrese LH, Dickler H, Schned E, et al. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis and Rheumatism 2002;46(5):1309-1318.
Schousboe JT, DeBold CR, Bowles C, Glickstein S, Rubino RK. Prevalence of vertebral compression fracture deformity by X-ray absorptiometry of lateral thoracic and lumbar spines in a population referred for bone densitometry. Journal of Clinical Densitometry 2002;5(3):239-246.
Back
| PARK NICOLLET RECOGNIZES OUR INDUSTRY PARTNERS AND COLLABORATORS FOR THEIR GENEROUS SUPPORT. |
Abbott Laboratories
Actelion Inc.
Agency for Healthcare Research
and Quality
Agilent Technologies
Agouron Pharmaceuticals Inc.
ALK Abello
Amgen Inc.
American Academy of Family Practice
American College of Surgeons
American Health Foundation
American Heart Association
Amylin
Animas Corporation
Ascension Orthopedics Inc.
Association of Rehabilitation Nurses
AstraZeneca LP
Aurora Imaging Technology Inc.
Auxilium Pharmaceuticals Inc.
Avanta Orthopedics
Aventis Pharmaceuticals
Bayer Corporation
Becton Dickinson
Boehringer Ingelheim Pharmaceuticals
Bristol-Myers Squibb Company
Bristol-Myers Squibb Medical Imaging
CADx Medical Systems Inc.
Case Western Reserve University
Centers for Disease Control and Prevention
Chiron Therapeutics
Corgentech
Cygnus Inc.
Deltec Inc.
Dermik Laboratories Inc.
Disetronic Medical Systems Inc.
Eastman Kodak Health Imaging
Eisai Inc.
Elan Corporation
Patricia and Ronald Eldred Fund of
the St. Paul Foundation
Eli Lilly and Company
Elsevier-Saunders/Mosby
Ethicon Endo-Surgery Inc.
Fischer Imaging Corporation
Fluoroscan Inc.
Forest Pharmaceuticals Inc.
Galderma USA
Genentech Inc.
GlaxoSmithKline
Guidant Foundation
Hand Innovations Inc.
Hoffman-LaRoche Inc.
Hologic
Howmedica Osteonics
Humana Inc.
Hypoguard USA Inc.
IDEC Pharmaceuticals Corporation
ImClone
Janssen Pharmaceutica
King Pharmaceuticals
Lakeland Health Services
Lineberry Research Associates
Lifescan Inc.
MedImmune Inc.
MediSense Inc.
Merck & Co. Inc.
Methodist Hospital
Metrika Inc.
Minneapolis Medical Research Foundation
Minnesota Medical Foundation
Minnesota Partnership for
Action Against Tobacco
Mitek Products |
Mylan Pharmaceuticals
National Cancer Institute
National Heart, Lung, and
Blood Institute
National Institute of Neurological
Disorders and Stroke
National Institutes of Health
Novartis Pharmaceuticals
Novo Nordisk Pharmaceuticals Inc.
Nycomed-Amersham
Orphan Medical Inc.
Ortho Biotech Products LP
OrthoLogic
Ortho-McNeil Pharmaceutical Inc.
Park Nicollet Clinic
Park Nicollet Foundation
Park Nicollet Health Services
PenRad Technologies Inc.
The Pfizer Foundation
Pfizer Inc.
Pharmaceutical Discovery Corporation
Pharmacia
PharmaMar
Primary Surgical Inc.
Procter & Gamble
Purdue Pharma LP
The Robert Wood Johnson Foundation
Roche Diagnostics
Roche Laboratories Inc.
Rheumatoid Arthritis Investigational
Network
Sanofi-Synthelabo
Schering Corporation
Schott Foundtion
Scios Inc.
SenoRx
Sepracor Inc.
SkyePharma Inc.
Solvay Pharmaceuticals Inc.
Stryker Leibinger
Survivalink
Takeda Pharmaceuticals America Inc.
TAP Pharmaceuticals Inc.
TheraSense Inc.
Tonkawa Inc.
TriMed Inc.
Trimeris Inc.
University of California, Los Angeles
University of Minnesota
Upsher-Smith Laboratories Inc.
Vical Inc.
Wallace Pharmaceuticals
Wright Medical
Wyeth
Zimmer Page & Associates
|
|
|
DONOR CONTRIBUTIONS ARE MORE THAN GIFTS. THEY ARE EXPRESSIONS OF SHARED VALUES THAT EVENTUALLY LEAD TO SHARED POSITIVE OUTCOMES FOR THOSE WE SERVE. THE SCHOTT FOUNDATION'S LONG-TERM CHARITABLE GIVING IN RHEUMATOLOGY, FOR EXAMPLE, HELPED ESTABLISH PARK NICOLLET'S OSTEOPOROSIS CENTER.
MANY THANKS TO ALL WHO SHARE OUR MISSION.
Susan and David Abelson, MD
Mary Ellen Abramson
Acorn Cardiovascular
Fred and Betty Ainslie
Nancy and Don Amren, MD
Rusk and Arnold Anderson, MD
Lawrence J. Anderson
Renner S. Anderson, MD, and
Martha M. Anderson, MD
Mr. and Mrs. Allen Arneson
Frank W. Babka
Jeanne Baribeau
Robert and Ramona Barney
Deloris Barton
Robert and Rita Beard
Earle and Elisabeth Bennett, MD
Carol and Richard Bergenstal, MD
Harley E. Bergren
JoAnn Berkland
Cathy Bishop
Joan Bissen
BJ Transport
Max A. Boller, MD
Deborah and William D. Borkon, MD
Carolyn Bowles, MD
Rick and Mary Ellen Boyd
Sandra and Michael Brandt
Kent K. Bratten, MD
Barbara L. Braun, PhD
Iverne Brill
Jacqueline and S. Buddy Bronstien
Robert and Sherry Broskoff
Corrine Buck
Edward Buckmaster
Judy A. Burdick
Bruce E. Burnett, MD, and
Jeanne Hesse, MD
Irene Butler
Mary Campbell
Carlson Companies
Debra Casserly
Debra Chamberlain
Lloyd and Virginia Chambers
Jean Chorzempa
Diane R. Christ
Robert D. Christensen, MD
Kenneth and Barbara Clark
Margueriette G. Clark
Julie Clarke Wilson
Thomas Cleary
James and Joanne Coleman
Nancy M. Collins, MD
V. Ross Collins, MD
Mr. and Mrs. Robert Costigan
Glen and Cheryl Craft
Roberta and James Craig, MD
Gary Cramer, MD
Janice Y. Creamer
Marilyn and James Dahl, MD
Joanna K. Dake
Dan and Kathleen Danford
Ruth E. Davidson
Thomas J. Davis, MD
Deer Creek Lions
Ann Deshler
Craig Dickson
Terri Dobratz
Ernest and Mary Dorn
Anna Draper
Donald and Linda DuBois
Duluth Lions Club
Peter E. Dyrud, MD
Eagan Lions Club
Tracy Eickhoff
Carol Evers
Michael J. Feldman, MD
Steve and Debbie Feldman
Bradford and Frances Finch
1st Choice Chiropractic, LLC
Lisa H. Fish, MD
Eva J. Fishman
Christine Follett
Rodney H. Forristall
Jean L. Forster
R. Carol Foster
Jinnet Briggs Fowles, PhD
Heather Fraser
Laura A. Frazier
Ronald and Janet Freund
Heather Gantzer, MD, and
Charles Gantzer, PhD
GCIU Local 1-M
Lisa Gears, MD
Sandra Geers
Richard Gomez
Howard and Liz Gourwitz
Bonnie and David F. Graft, MD
Arlene Gralnek
Janet Hagen
Bruce and Barbara Halgren
Gail and A. Stuart Hanson, MD
Frances E. Hanson
Susan M. Hanson
Keith R. Harmon, MD
Patricia L. Haroldson
Barney and Pamela Harris, MD
Krista K. Haslach
John and Linda Haugen
Ilene and Leland Haugen
Margo Struthers and J. Mark
Haugland, MD
Margaret L. Healey
Mary Heintz
Margaret A. Heisel, MD
R. Stephen and Kathleen Held
Lynnae Hess
Julayne Hill
Annette Hiltz
Renee Holm
H. Spencer Holmes, MD
David C. Homans, MD
Janet and Jerry Huttner
Marie Iseminger
Rodney and Marjorie Jenkins
Julie and Chris Johnson, MD
Lawrence and Jane Johnson
Patricia A. Johnson
Lori and Paul Johnson, MD
Anne Frank Jones and Thomas A.
Jones, MD
Cherie Kammerer
Michael Kelley
Lauren Kelner
Robert Kim, MD
King, Brown and Partners
Leona Kirkham
Merna Knippling
Irving H. Koponen
Rebecca Kranz
Mary M. Kruse
Linda S. Kuno
Edith Kynell
Laurie Kynell
William Kynell
Kathy LaMere
Deb Lasher
Ellen and Wayne F. Leebaw, MD
Maurice and Beatrice Leenay
Gregory T. Lehman, MD
Linda and Mike Leimer
Donald and Julia Levitt
Irving and Shirley Levitt
Diane and Michael Levy, MD
Michelle Lewerenz
Juliet C. Lilgaroth, MD
Lions Club of Emily, Outing and 50 Lakes
Lions Club of Northeast Minneapolis Charitable Gaming
Lions District 5M2
Lions District 5M8
Lions District 5M9
Lions MD5M Diabetes Committee
Channing T. Lipson, MD
Holly E. Lund
Sheila Luxford
Joanne and Edward Maeder,Jr., MD
Teresa Mars |
Robert W. and Margaret Marshall
Douglas M. Martin, MD
Myron and Lois Martin
Steven Mattson
Carla Matyasz
Nancy McCaffrey
Mark and M. Katie McCartan
Bev and Charles McCoy, MD
Jody McDermott-Baty
Jane McDowell-Johnson
Scott A. McPherson, MD
Lloyd and Drusilla Meese
Cynthia and M. Mark Melin, MD
Merry Weather Workers 4-H Club
Evan and Betty Merz
Andrea Messina, MD
Stephanie Meyer and John Levy
Elizabeth A. Michel
Mary Zitur Miley, MD, and
Timothy G. Miley, MD
Brenda Miller
Mary and Jerome Miller
Nancy Miller
Miltona Lions Club
Lewis and Jill Mithun
Donald and Patricia Moberg
Bjorn K. Monson, MD
Susan F. Mooney
Osborne and Alice Morken
Muriel C. Morrow
William and Sherrill Mozey
Caren M. Nash
Joe Nelson
Dixie Ness
Thaddeus and Juanita Nicholas
D. James Nielsen
Wayne Nispel
Karen and Leonard Nordstrom, MD
Susan Norha
Jane Norstrom
Brian O'Leary
Gary J. Olafson
Dale and Nancy Olseth
Geneva Olson
Roberta and Ken Olson, MD
Lois and Robert D. Olson
Vern and Wanda Olson
Omega Chi Chapter 5360
David and Leanne Otterdahl
Roy and Carol Palmquist
Mary Pappas
Janice Pearson
Laura Perron
Vicki Perske
Barbara and Charles Peterson, MD
Susan A. Peterson
Alma Petrini
Julie Pettit
Anthony L. Pojman, DPM
Leland Pommrehn
Charlene Postigo
Stephen H. Powless, DPM
Leslie Pratt, MD
Scott and Amy Priddy
Marilyn and Timothy Pryor, MD
Sue and Judson Reaney, MD
Betty and John A. Reichert, MD
June A. Reichert
Jayne and Roger Rhodes, MD
Ralph Richardson
Hedwig Riesgraf
Nancy A. Riess
Timothy and Kathleen Riordan
Susan Roufs
Ranelle Rubino
Darrell and Gloria Rumsey
Lee and Marguerite Rush
Laurel Paller-Rzepka and
Andrew Rzepka, MD
Lisa A. Sauer
Curtis Savstrom
Ann Schaeffer and family
Greg Rudisill and Janet Schaffer, MD
Barbara and William Schoenwetter, MD
Nory Scholten
Schott Foundation
Mary Merrill and
Michael Schueppert, MD
Susan Schumacher
Larry A. Searcy
Dwaine and Dawn Sexton
Claudette A. Shafer
Jeffrey and Nanci Shapiro
Dianne M. Shimek
Thomas and Myrna Skalsky
Bervin and Arlene Skjei
Duane and Carmen Skophammer
Kristin Smith
South Strand Lions Club
Cheryl Spangler
Robert and Judith Specht
Clinton and Violet Sprain
Catherine Spurr
Renee St. Jacque
Candace Staples
Patricia A. Stephens
Norman Sterrie, MD
Tamara and Craig H. Stibal, MD
Stony Brook Township Charities Fund
Marib P. Storey
Janette Hansen Strathy, MD
George S. Strauss, MD
Ruth Stricker
Ellie and David Strock
Donald and Dorothy Stuber
Maria Helene and John Thomas Suh, MD
Ferne Svetlin
Richard J. Sveum, MD
M. J. Swanson
Karen K. Swenson
Janis Taramelli
Gail and Paul Terry, PhD
Emily Tessmer
Gregory Thaemert
Maureen Chevalier and
Mark K. Thomas, MD
Deb Thorp, MD, and Kathleen Murphy
Maria Thrall
Gerald W. Timm, PhD
Tinklenberg Lumber
Cynthia Toher
Susan J. Torkelson, MD
James V. and Sharon Toscano
Richard and Ann Trainer
Donna M. Turchetti, MD
The Twin City District Dietetic Association
Twin City Golf Club
Rachel Vieyra
Carolyn and David Von Weiss, MD
Alex Vongries, MD
Phyllis L. Wagner
Ross Wagner
Monica Walczak
Nancy Waldbillig
Elayna Walker
Jean Wanha
Elizabeth Waverek
Wayzata Lions Club
Ted Wegleitner
Kimberley Weigel
W. Gregory Weisshaar, MD
Mary Beth Weldon
David and Patti Wessner
Nancy and Robert Wetherille, MD
Peg and Dick Woellner, MD
Joseph and Caroline Wonderly
Judith Workman
Richard A. Wyatt, MD
Sharon Yorde
George Youland
David Yurik
Grace V. Yurik
Grace and Richard Yurik
Elvera and Clarence Zacherson
G. Kevin Zhang, MD, and Anna Hsu
Martha Ziehwein
|
|
|
| REVENUES |
2002 |
2001 |
| PUBLIC SUPPORT |
|
|
 Grants |
8,850,239 |
7,945,851 |
| Unrestricted contributions |
5,629,747 |
2,040,308 |
|
14,479,986 |
9,986,159 |
| OTHER |
|
|
| Professional services |
3,740,755 |
3,456,736 |
| Tuition |
987,341 |
1,133,291 |
| Investment income |
1,052,441 |
1,171,965 |
| Publication sales, net |
1,084,471 |
1,038,258 |
| Other |
50,805 |
51,515 |
| Total revenues from other sources |
6,915,813 |
6,851,765 |
| TOTAL REVENUES |
21,395,799 |
16,837,924 |
|
|
|
| |
|
|
| EXPENSES |
|
|
| Program |
16,980,489 |
14,264,757 |
| General and administrative |
2,318,398 |
1,359,023 |
| Fund-raising |
175,764 |
143,202 |
| TOTAL EXPENSES |
19,474,651 |
15,766,982 |
| OPERATIONS SURPLUS |
1,921,148 |
1,070,942 |
|
Realized nonoperations investment income (loss) |
|
(1,635,416) |
(1,091,194) |
|
Unrealized investment income (loss) |
|
(1,186,823) |
(865,803) |
|
NET EXCESS (DEFICIT) OF REVENUES OVER EXPENSES
|
(901,091) |
(886,055) |
|
|
|
| |
|
|
| ASSETS |
2002 |
2001 |
| Cash and investments |
15,597,657 |
18,077,300 |
| Grants, pledges receivable |
5,417,518 |
5,347,572 |
| Accounts receivable |
858,593 |
802,441 |
| Inventory |
267,693 |
451,426 |
| Property and equipment, net |
861,740 |
344,797 |
| Other |
112,537 |
112,242 |
| TOTAL ASSETS |
23,115,738 |
25,135,778 |
|
|
|
| |
|
|
| LIABILITIES |
|
|
|
Grants and pledges designated for future periods |
|
7,812,183 |
8,097,995 |
|
Accounts payable and accrued expenses |
|
1,210,115 |
2,182,870 |
| Other |
187,494 |
47,881 |
| TOTAL LIABILITIES |
9,209,792 |
10,328,746 |
| NET ASSETS |
13,905,946 |
14,807,032 |
| TOTAL LIABILITIES AND NET ASSETS |
23,115,738 |
25,135,778 |
|
|
|
| PARK NICOLLET INSTITUTE MAINTAINS NUMEROUS WEB SITES TO CONNECT WITH FRIENDS, SUPPORTERS AND CUSTOMERS. |
|
Park Nicollet Institute
www.parknicollet.com/institute The Institute’s gateway site.
Park Nicollet HealthSource
www.healthsource.org An e-commerce site for Institute publications that also includes information on HealthSource’s worksite services.
Health Education Classes
www.parknicollet.com/clinic/classes/classes.html Information on health education classes, services and forums.
Risk Adjustment Impact Study
www.riskadjustment.org Online support for the Risk Adjustment Impact Study — funded by The Robert Wood Johnson Foundation.
Health Advisor
www.parknicollet.com/healthadvisor Park Nicollet’s online self-care resource that provides current, reliable information on more than 125 health topics to help patients and the public care for common conditions and make personal health decisions.
International Diabetes Center
www.internationaldiabetescenter.com A variety of resources for health professionals and people with diabetes.
IDC Publishing
www.idcpublishing.com An e-commerce site marketing current diabetes educational products.
Community Clinical Oncology Program
www.ccopnet.com Information about the Metro-Minnesota Community Clinical Oncology Program.
Continuing Medical Education
www.parknicollet.com/cme Information on continuing medical education conferences and lectures.
|
|
|
IN 2002, PAUL E. TERRY, PHD, REPLACED A. STUART HANSON, MD, WHO SERVED AS THE INSTITUTE’S PRESIDENT FOR 16 YEARS. HANSON RETIRED FROM THE PRESIDENCY BUT REMAINS ON THE INSTITUTE’S BOARD OF DIRECTORS.
|
OFFICERS
Barbara Colombo, BSN, JD
Chair
Community Volunteer
Laura Waterman Wittstock
Vice Chair
Migizi Communications
Paul E. Terry, PhD
President and Chief Executive Officer
Park Nicollet Institute
James V. Toscano
Executive Vice President and
Chief Operating Officer
Park Nicollet Institute
David Abelson, MD
Treasurer
Park Nicollet Clinic
Mary Miley, MD
Secretary
Park Nicollet Clinic
Renner Anderson, MD
Vice President for Research
Park Nicollet Clinic
David M. Kendall, MD
Vice President for Education
International Diabetes Center
Curtis Savstrom
Controller
Park Nicollet Institute
David Cooke
Assistant Treasurer
Park Nicollet Health Services
Mary Heintz
Assistant Secretary
Park Nicollet Institute
D. James Nielsen, JD
Counsel
Gray Plant Mooty Mooty & Bennett
DIRECTORS EMERITUS
Don Amren, MD
Park Nicollet Clinic (retired)
Arnold Anderson, MD
Park Nicollet Clinic (retired)
Minneapolis Children’s Medical Center
(retired)
Donnell D. Etzwiler, MD
International Diabetes Center (retired)
|
DIRECTORS
Nancy Bologna, PhD
Best Buy
Bruce Burnett, MD
Park Nicollet Clinic
Samuel Carlson, MD
Park Nicollet Health Services
Jean Forster, PhD, MPH
University of Minnesota
A. Stuart Hanson, MD
Park Nicollet Clinic
David Homans, MD
Park Nicollet Heart Center
Michael J. Johnson
Park Nicollet Foundation
Nicole Lurie, MD
Rand Corporation
The Rev. Donald Meisel, PhD, DD
Westminster Presbyterian Church
(retired)
Abdirahman Mohamed, MD
Park Nicollet Clinic
Ben Oehler
Waycrosse Inc.
Sue A. Ravenscraft, MD
Park Nicollet Clinic
Janet Schaffer, MD
Park Nicollet Clinic
Eric Schned, MD
Park Nicollet Clinic
Peter J. Throdahl
Justus Lumber Company
Gregory M. Vercellotti, MD, FACP
University of Minnesota
Thomas Walsh, MD
Park Nicollet Clinic
David Wessner
Park Nicollet Health Services |
|
|
|
PAUL E. TERRY, PHD, WAS NAMED PRESIDENT AND CEO OF PARK NICOLLET INSTITUTE IN 2002 AFTER 15 YEARS AS THE INSTITUTE’S VICE PRESIDENT OF EDUCATION. HE WAS A KELLOGG NATIONAL LEADERSHIP FELLOW AND A SENIOR FULBRIGHT SCHOLAR AT THE UNIVERSITY OF ZIMBABWE WHERE HE RESEARCHED HIV PREVENTION AND TAUGHT PUBLIC HEALTH.
|
ADMINISTRATION AND FINANCE
Paul E. Terry, PhD
President and Chief Executive Officer
James V. Toscano
Executive Vice President and
Chief Operating Officer
Curtis Savstrom, MBA, CPA, CISA
Controller
PRODUCT DEVELOPMENT
AND PUBLISHING
Karol M. Carstensen
Executive Director,
Park Nicollet Health Innovations
EDUCATION
David M. Kendall, MD
Vice President for Education
Joan Bissen, RD
Director, Health Education Center
Ted Wegleitner, MBA
Executive Director,
Park Nicollet HealthSource
INTERNATIONAL DIABETES CENTER
Richard M. Bergenstal, MD
Senior Vice President and Executive Director
David M. Kendall, MD
Chief of Clinical Services
Roger Mazze, PhD
Vice President and Chief Academic Officer
Beth Schneider, MA
Patient Services Administrator
Ellie Strock, ANP
Vice President and Chief of
Professional Services
|
RESEARCH
Renner Anderson, MD
Vice President for Research
Jinnet B. Fowles, PhD
Senior Vice President and
ExecutiveDirector, Health
Research Center
|
|
|
